Form 4 for MRK Merck & Co.
Accepted 2022-05-03 00:00:00 ET · period of report 2022-05-01 · accession 0001127602-22-013015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-03 | 2022-05-01 | MRK | Garay Arpa | SVP Human Health Gbl Mktg | M - OptEx | $88.69 | +866 | 1,156 | +299% | +$76.8K |
| D | 2022-05-03 | 2022-05-01 | MRK | Garay Arpa | SVP Human Health Gbl Mktg | F - Tax | $88.69 | -247 | 909 | -21% | -$21.9K |
| D | 2022-05-03 | 2022-05-01 | MRK | Garay Arpa | SVP Human Health Gbl Mktg | M - OptEx | $0.00 | -866 | 866 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-01 | M | A | 866 | $88.69 | 1,156 | D | — | — | |
| 2 | Common | Common Stock | 2022-05-01 | F | D | 247 | $88.69 | 909 | D | — | — | (F1) Holdings include shares acquired in dividend reinvestment transactions. |
| 3 | Derivative | Restricted Stock Unit | 2022-05-01 | M | D | 866 | $0.00 | 866 | D | — · 2021-05-01 to 2023-05-01 | 866 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F3) These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023. |